DynaMed. Any time, An y w here

Transcription

1 DynaMed Access DynaMed Any time, An y w here

2 DynaMed DynaMed is a clinical reference tool created by physicians for physicians and other health care professionals for use at the point-ofcare. With thousands of topics, DynaMed is an indispensable resource for answering clinical questions during practice. DynaMed balances the latest content and resources with validity, relevance and convenience to create the most useful clinical resource possible. Updated daily, DynaMed applies a 7-step systematic evidencebased process to all of its content, assuring that the science backing the conclusions is sound. Why Would I Use DynaMed? A product of EBSCO Health Improve health outcomes and reduce health care costs by using the best available evidence for clinical decision-making Quickly obtain pertinent information right at the point-of-care Keep abreast of the latest medical research with daily updates through DynaMed s Systematic Literature Surveillance Earn Continuing Medical Education (CME) credits How Do I Access DynaMed? You can access DynaMed from workstations throughout your institution and from your mobile device. (Contact your administrator for details about how to take advantage of mobile access.) Use the information below to log in to DynaMed remotely. Access URL: User Name: Password: Help Contact: Content information on reverse side...

3 Content, eatures & unctionality at a Glance Easy, Powerful Searching Search by keyword or browse alphabetically by specific topic or by category Content Spotlight Content in this section is updated frequently to highlight clinically relevant news and information Evidence-Based Methodology View details on DynaMed s 7-step editorial process for determining the best available evidence Easily navigate to other relevant medical resources directly from DynaMed, including EBSCO databases (subscription required) Recent Updates Quickly view a list of the most recently updated topic summaries EBM ocus Newsletter Sign up for DynaMed s free newsletter to receive updates on timely and significant changes from articles most likely to change clinical practice. ree CME credit is available Spotlight DynaMed shown to be THE MOST CURRENT point-of-care reference (BMJ 2011 Sep 23) DynaMed 7-Step Evidence-Based Methodology Introducing Practice Changing Updates ST-elevation myocardial infarction (STEMI) updated with ESC/ACC/AHA/WH 2012 universal definition of MI (Eur Heart J 2012 Oct) Obstructive sleep apnea (OSA) in children updated with AAP recommendations (Pediatrics 2012 Sep) Streptococcal pharyngitis updated with IDSA recommendations (Clin Infect Dis 2012 Sep 9) DYNAMED WEEKLY UPDATE: Regular Aspirin Use After Diagnosis of Colorectal Cancer May Reduce Mortality in Patients with Tumor PIK3CA Mutation 1 Browse: A B C D E G H I J K L M N O P Q R S T U V W X Y Z EBSCO Support Site Online Privacy Policy Terms of Use Copyright 2012 EBSCO Industries, Inc. All Rights Reserved. 4 PERC LEXI-COMP Browse Categories NRC SMART IMAGEBASE

4 Hover unctionality Hover over a topic to see the full table of contents Linking Navigation Navigate directly to a topic section from the search result list Related Search Results View relevant search results from related EBSCO databases (subscription required) CME Earn continuing education credits Navigation View and select subsections of DynaMed topics for direct access to specific sections Comments to the Editor Send feedback directly to the DynaMed editorial team Search within Text Search for terms within the body text of topic summaries Level of Evidence Labeling Quickly discern the quality of evidence via easyto-interpret Level of Evidence labels Internal Topic Linking Easily jump to other related sections of a topic via embedded links ull Text Links Access ull Text medical Journals quickly and easily (subscription required). Get CME for this Topic + Related Summaries + General Information + Causes and Risk actors + Complications and Associated Conditions + History and Physical + Diagnosis Treatment Treatment Overview + Medications + Surgery and procedures ollow-up + Prognosis + Prevention and Screening + Quality Improvement + Guidelines and Resources Patient Information + ICD-9/ICD-10 Codes + References Patient Education Reference Center Send Comment to Editor Result List 1 of 16 Expand All Collapse All A A A Search within text Result List 1 of 16 Expand All Collapse All A A A Search within text 13 mortality in 12% vs. 9% (p = 0.36) elective surgery for AAA in 20% vs. 26% (p = 0.11) cessation of study medication in 42.4% vs. 26.8% (p = ) withdrawal due to adverse effects 38% vs. 21% (NNH 6) Reference - J Vasc Surg 2002 Jan;35(1):72 in J Watch Mar 15;22(6):46 propranolol poorly tolerated and might increase mortality (level 2 [mid-level] evidence) based on small randomized trial with high dropout rate 54 patients with small AAA diagnosed on screening were randomized to propranolol 40 mg vs. placebo orally twice dailyvs. placebo for mean 2.5 years mortality in 16.7% vs. 4.2% (relative risk [RR] = 1.6, 95% CI ) dropout rate 60% vs. 25% (RR = 1.74, 95% CI ) ACE inhibitors: ACE inhibitors reported to be associated with reduced risk of ruptured AAA (level 3 [lacking direct] evidence) based on case-control study retrospective study of 15,326 patients > 65 years old admitted to hospital for AAAvs. placebo for mean 2.5 years 3,379 (22%) had ruptured AAA and 11,947 (78%) had intact AAA ACE inhibitor use reported in 665 (20%) with ruptured AAA vs. 2,761 (23%) with intact AAA (odds ratio 0.82, 95% CI ) no statistically significant associations found for beta blockers, calcium channel blockers, alpha blockers, angiotensin receptor blockers, or thiazide diuretics Reference - Lancet 2006 Aug 19;368(9536):659 EBSCOhost ull Text editorial can be found in Lancet 2006 Aug 19;368(9536):622 EBSCOhost ull Text Am am Physician 2006 Nov 15;74(10):1780 Get CME for this Topic + Related Summaries + General Information + Causes and Risk actors + Complications and Associated Conditions + History and Physical + Diagnosis Treatment Treatment Overview + Medications + Surgery and procedures ollow-up + Prognosis + Prevention and Screening + Quality Improvement + Guidelines and Resources Patient Information + ICD-9/ICD-10 Codes + References Patient Education Reference Center Send Comment to Editor 9 mortality in 12% vs. 9% (p = 0.36) 14 elective surgery for AAA in 20% vs. 26% (p = 0.11) cessation of study medication in 42.4% vs. 26.8% (p = ) withdrawal due to adverse effects 38% vs. 21% (NNH 6) Reference - J Vasc Surg 2002 Jan;35(1):72 in J Watch 2002 Mar 15;22(6):46 propranolol poorly tolerated and might increase mortality (level 2 [mid-level] evidence) based on small randomized trial with high dropout rate 54 patients with small AAA diagnosed on screening were randomized to propranolol 40 mg vs. placebo orally twice dailyvs. placebo for mean 2.5 years mortality in 16.7% vs. 4.2% (relative risk [RR] = 1.6, 95% CI ) dropout rate 60% vs. 25% (RR = 1.74, 95% CI ) ACE inhibitors: ACE inhibitors reported to be associated with reduced risk of ruptured AAA (level 3 [lacking direct] evidence) based on case-control study retrospective study of 15,326 patients > 65 years old admitted to hospital for AAAvs. placebo for mean 2.5 years 3,379 (22%) had ruptured AAA and 11, (78%) had intact AAA ACE inhibitor use reported in 665 (20%) with ruptured AAA vs. 2,761 (23%) with intact AAA (odds ratio 0.82, 95% CI ) no statistically significant associations found for beta blockers, calcium channel blockers, alpha blockers, angiotensin receptor blockers, or thiazide diuretics Reference - Lancet 2006 Aug 19;368(9536):659 EBSCOhost ull Text editorial can be found in Lancet 2006 Aug 19;368(9536):622 EBSCOhost ull Text Am am Physician 2006 Nov 15;74(10): Create alerts, print and topic summaries, or generate persistent links to a topic 12 16

5 What will I find in DynaMed? One-click access to full-text articles Ability to earn CMEs Alerts when topics are updated Practice changing updates Clinical Calculators Guidelines Easy access from EMRs EBM ocus e-newsletter ICD-9 and ICD-10 codes EBSCO Industries, Inc. Printed in U.S.A. (1013) EBS-2758